Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantitative Whole-Body Diffusion-weighted MRI after One Treatment Cycle for Aggressive Non-Hodgkin Lymphoma Is an Independent Prognostic Factor of Outcome.
De Paepe KN, Van Keerberghen CA, Agazzi GM, De Keyzer F, Gheysens O, Bechter O, Wolter P, Dierickx D, Janssens A, Verhoef G, Oyen R, Koole M, Vandecaveye V. De Paepe KN, et al. Among authors: verhoef g. Radiol Imaging Cancer. 2021 Mar 26;3(2):e200061. doi: 10.1148/rycan.2021200061. eCollection 2021 Mar. Radiol Imaging Cancer. 2021. PMID: 33817648 Free PMC article.
Detection of bone marrow involvement in newly diagnosed post-transplant lymphoproliferative disorder: (18)F-fluorodeoxyglucose positron emission tomography/computed tomography versus bone marrow biopsy.
Gheysens O, Thielemans S, Morscio J, Boeckx N, Goffin KE, Deroose CM, Sagaert X, Wlodarska I, Verhoef G, Dierickx D, Tousseyn T. Gheysens O, et al. Among authors: verhoef g. Leuk Lymphoma. 2016 Oct;57(10):2382-8. doi: 10.3109/10428194.2016.1140162. Epub 2016 Feb 8. Leuk Lymphoma. 2016. PMID: 26854937
Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study.
Vandenberghe P, Wlodarska I, Tousseyn T, Dehaspe L, Dierickx D, Verheecke M, Uyttebroeck A, Bechter O, Delforge M, Vandecaveye V, Brison N, Verhoef GE, Legius E, Amant F, Vermeesch JR. Vandenberghe P, et al. Among authors: verhoef ge. Lancet Haematol. 2015 Feb;2(2):e55-65. doi: 10.1016/S2352-3026(14)00039-8. Epub 2015 Jan 20. Lancet Haematol. 2015. PMID: 26687610
Positron emission tomography in mantle cell lymphoma.
Brepoels L, Stroobants S, De Wever W, Dierickx D, Vandenberghe P, Thomas J, Mortelmans L, Verhoef G, De Wolf-Peeters C. Brepoels L, et al. Among authors: verhoef g. Leuk Lymphoma. 2008 Sep;49(9):1693-701. doi: 10.1080/10428190802216707. Leuk Lymphoma. 2008. PMID: 18798104 Clinical Trial.
Blinatumomab in relapsed/refractory diffuse large B cell lymphoma.
Van Dijck R, Janssens A, Dierickx D, Delforge M, Gheysens O, Tousseyn T, Verhoef G. Van Dijck R, et al. Among authors: verhoef g. Ann Hematol. 2017 Oct;96(10):1759-1762. doi: 10.1007/s00277-017-3088-5. Epub 2017 Aug 5. Ann Hematol. 2017. PMID: 28779352 No abstract available.
Physical activity and risk of lymphoma: a meta-analysis.
Vermaete NV, Wolter P, Verhoef GE, Kollen BJ, Kwakkel G, Schepers L, Gosselink R. Vermaete NV, et al. Among authors: verhoef ge. Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1173-84. doi: 10.1158/1055-9965.EPI-13-0182. Epub 2013 May 15. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 23677574 Review.
273 results